Patricia S Grace,Joshua M Peters,Jaimie Sixsmith,Richard Lu,Brooke A Fenderson,Andrew Vickers,Matthew D Slein,Edward B Irvine,Tanya McKitrick,Mo-Hui Wei,Richard D Cummings,Aaron Wallace,Lisa Cavacini,Alok K Choudhary,Megan K Proulx,Christopher Sundling,Gunilla Källenius,Rajko Reljic,Joel D. Ernst,Arturo Casadevall,Camille Locht,Abraham Pinter,Christopher M Sassetti,Bryan D Bryson,Sarah M Fortune,Galit Alter

Abstract:Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a leading cause of death by an infectious disease globally, with no efficacious vaccine. Antibodies are implicated in Mtb control, but the mechanisms of antibody action remain poorly understood. We assembled a library of TB monoclonal antibodies (mAb) and screened for the ability to restrict Mtb in mice, identifying protective antibodies targeting known and novel antigens. To dissect the mechanism of mAb-mediated Mtb restriction, we optimized a protective lipoarabinomannan-specific mAb through Fc-swapping. In vivo analysis of these Fc-variants revealed a critical role for Fc-effector function in Mtb restriction. Restrictive Fc-variants altered distribution of Mtb across innate immune cells. Single-cell transcriptomics highlighted distinctly activated molecular circuitry within innate immune cell subpopulations, highlighting early activation of neutrophils as a key signature of mAb-mediated Mtb restriction. Therefore, improved antibody-mediated restriction of Mtb is associated with reorganization of the tissue-level immune response to infection and depends on the collaboration of antibody Fab and Fc.

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: How to limit the growth and spread of Mycobacterium tuberculosis (Mtb) through the functional characteristics of antibodies, especially the roles of their Fab and Fc regions. Specifically, the research aims to: 1. **Screen monoclonal antibodies (mAb) that can limit the growth of Mtb**: By constructing a monoclonal antibody library against multiple antigens of Mtb, screen out antibodies that can effectively limit the growth of Mtb in mice. 2. **Explore the roles of the Fab and Fc regions of antibodies in Mtb control**: By exchanging the Fc regions of antibodies to generate different Fc variants, study the effects of these variants on Mtb control. In particular, study how the functions of the Fc region (such as Fc receptor - binding ability, complement - recruiting ability, etc.) affect the antibacterial effects of antibodies. 3. **Analyze the effects of Fc variants on the distribution and function of immune cells**: Through single - cell transcriptomics analysis, study the changes in the distribution and activation states of lung immune cells after treatment with different Fc variants, in order to reveal how antibodies limit Mtb infection through cooperation with the immune system. 4. **Explore the antibody - mediated Mtb - limiting mechanisms**: Through a series of in - vivo and in - vitro experiments, explore how antibodies promote the control of Mtb through Fc effector functions (such as phagocytosis, complement activation, etc.), and how these effects affect the distribution and growth of Mtb in different immune cells. Overall, this paper aims to deeply understand the specific mechanisms of antibodies in immune protection against tuberculosis, especially the role in Fc effector functions, and provide a theoretical basis for the development of new anti - tuberculosis treatment methods.

Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction.